Kimberly Briggs

Kimberly Briggs is an accomplished professional in the field of cellular and molecular medicine with extensive experience in various leadership roles. Notable positions include Director, Associate Director, and Principal Scientist at Tango Therapeutics, as well as a Consultant at Third Rock Ventures. Kimberly also served as a Postdoctoral Fellow at Dana-Farber Cancer Institute. Educational qualifications include a PhD in Cellular and Molecular Medicine from The Johns Hopkins University School of Medicine and a BS in Biology from William & Mary.